Vitreal IGF-I levels were found to be increased in diabetic patients and IGF-I seems to be involved in retinal neovascularization, which is the primary determinant of prematurity-related retinopathy and proliferative diabetic retinopathy [28]. Here, IGF1 is linked to proliferative diabetic retinopathy.